S, B., PV, N., AB, A., A, H., & ST, T. (2025). Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy. Expert opinion on investigational drugs, 34(10), 755. https://doi.org/10.1080/13543784.2025.2573647
Chicago Style (17th ed.) CitationS, Bleve, Nuzzo PV, Arham AB, Holmes A, and Tagawa ST. "Androgen Receptor Pathway Signaling Inhibitors in Development for Prostate Cancer Therapy." Expert Opinion on Investigational Drugs 34, no. 10 (2025): 755. https://doi.org/10.1080/13543784.2025.2573647.
MLA (9th ed.) CitationS, Bleve, et al. "Androgen Receptor Pathway Signaling Inhibitors in Development for Prostate Cancer Therapy." Expert Opinion on Investigational Drugs, vol. 34, no. 10, 2025, p. 755, https://doi.org/10.1080/13543784.2025.2573647.